Compare NWPX & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NWPX | PSNL |
|---|---|---|
| Founded | 1966 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 750.9M | 729.1M |
| IPO Year | 1996 | 2019 |
| Metric | NWPX | PSNL |
|---|---|---|
| Price | $118.75 | $11.54 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $70.00 | $12.20 |
| AVG Volume (30 Days) | 115.7K | ★ 2.7M |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 4.71 | ★ 33.58 |
| EPS | ★ 1.08 | N/A |
| Revenue | ★ $526,003,000.00 | $69,648,000.00 |
| Revenue This Year | $6.98 | $15.34 |
| Revenue Next Year | $3.30 | $41.46 |
| P/E Ratio | $110.83 | ★ N/A |
| Revenue Growth | ★ 6.79 | N/A |
| 52 Week Low | $38.46 | $3.84 |
| 52 Week High | $123.16 | $11.85 |
| Indicator | NWPX | PSNL |
|---|---|---|
| Relative Strength Index (RSI) | 67.24 | 76.48 |
| Support Level | $105.00 | $6.68 |
| Resistance Level | $123.16 | $11.28 |
| Average True Range (ATR) | 3.86 | 0.80 |
| MACD | -0.48 | 0.33 |
| Stochastic Oscillator | 75.00 | 85.27 |
NWPX Infrastructure Inc is a manufacturer of water-related infrastructure products, and operates in two segments, Water Transmission Systems (WTS), operating as the Northwest Pipe Company brand, and Precast Infrastructure and Engineered Systems (Precast), which includes the brands NWPX Geneva and NWPX Park. WTS manufactures large-diameter, high-pressure steel pipeline systems for use in water infrastructure applications, which are related to drinking water systems. Precast manufactures stormwater and wastewater technology products, high-quality precast and reinforced concrete products, including reinforced concrete pipe (RCP), manholes, box culverts, vaults, and catch basins, pump lift stations, oil water separators, biofiltration units, and other environmental and engineered solutions.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.